TD Cowen Downgrades Passage Bio Inc. (PASG) to Hold

April 21, 2026 9:04 AM

TD Cowen analyst Brendan Smith downgraded Passage Bio Inc. (NASDAQ: PASG) from Buy to Hold.The analyst comments "PASG released updated ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found